Cargando…

Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience

INTRODUCTION: Transfusion transmitted infections (TTIs) can cause threat to bloody safety as blood transfusion is an important mode of transmission of TTI to the recipient, hence, to prevent transmission of these diseases, screening tests on blood bags is an important step for blood safety. AIM: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandekar, Sushama A., Amonkar, Gaythri P., Desai, Heena M., Valvi, Nitin, Puranik, Gururaj V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607759/
https://www.ncbi.nlm.nih.gov/pubmed/28966492
http://dx.doi.org/10.4103/0974-2727.214246
_version_ 1783265332890173440
author Chandekar, Sushama A.
Amonkar, Gaythri P.
Desai, Heena M.
Valvi, Nitin
Puranik, Gururaj V.
author_facet Chandekar, Sushama A.
Amonkar, Gaythri P.
Desai, Heena M.
Valvi, Nitin
Puranik, Gururaj V.
author_sort Chandekar, Sushama A.
collection PubMed
description INTRODUCTION: Transfusion transmitted infections (TTIs) can cause threat to bloody safety as blood transfusion is an important mode of transmission of TTI to the recipient, hence, to prevent transmission of these diseases, screening tests on blood bags is an important step for blood safety. AIM: This study was undertaken with the aim of determining the seroprevalence of TTI in healthy blood donors in a tertiary care blood bank. MATERIALS AND METHODS: A retrospective study was carried out over a period of 5 years from January 2007 to December 2011. Serum samples were screened for hepatitis B surface antigen (HBsAg), antibodies to human immunodeficiency virus (HIV) Type 1 and 2, hepatitis c virus (HCV) and syphilis using enzyme-linked immunosorbent assays with the third generation kits and venereal disease research laboratory test, respectively. RESULTS: A total of 76,653 healthy donors were included out of which majority of donors were male (91.79%). The overall seroprevalence of HIV, HBsAg, HCV, and syphilis were 0.26%, 1.30%, 0.25%, and 0.28%, respectively. CONCLUSION: Methods to ensure a safety blood supply should be encouraged. For that, screening with a better selection of donors and use of sensitive screening tests including nucleic acid testing technology should be implemented.
format Online
Article
Text
id pubmed-5607759
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-56077592017-10-01 Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience Chandekar, Sushama A. Amonkar, Gaythri P. Desai, Heena M. Valvi, Nitin Puranik, Gururaj V. J Lab Physicians Original Article INTRODUCTION: Transfusion transmitted infections (TTIs) can cause threat to bloody safety as blood transfusion is an important mode of transmission of TTI to the recipient, hence, to prevent transmission of these diseases, screening tests on blood bags is an important step for blood safety. AIM: This study was undertaken with the aim of determining the seroprevalence of TTI in healthy blood donors in a tertiary care blood bank. MATERIALS AND METHODS: A retrospective study was carried out over a period of 5 years from January 2007 to December 2011. Serum samples were screened for hepatitis B surface antigen (HBsAg), antibodies to human immunodeficiency virus (HIV) Type 1 and 2, hepatitis c virus (HCV) and syphilis using enzyme-linked immunosorbent assays with the third generation kits and venereal disease research laboratory test, respectively. RESULTS: A total of 76,653 healthy donors were included out of which majority of donors were male (91.79%). The overall seroprevalence of HIV, HBsAg, HCV, and syphilis were 0.26%, 1.30%, 0.25%, and 0.28%, respectively. CONCLUSION: Methods to ensure a safety blood supply should be encouraged. For that, screening with a better selection of donors and use of sensitive screening tests including nucleic acid testing technology should be implemented. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5607759/ /pubmed/28966492 http://dx.doi.org/10.4103/0974-2727.214246 Text en Copyright: © 2017 Journal of Laboratory Physicians http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Chandekar, Sushama A.
Amonkar, Gaythri P.
Desai, Heena M.
Valvi, Nitin
Puranik, Gururaj V.
Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience
title Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience
title_full Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience
title_fullStr Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience
title_full_unstemmed Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience
title_short Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience
title_sort seroprevalence of transfusion transmitted infections in healthy blood donors: a 5-year tertiary care hospital experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607759/
https://www.ncbi.nlm.nih.gov/pubmed/28966492
http://dx.doi.org/10.4103/0974-2727.214246
work_keys_str_mv AT chandekarsushamaa seroprevalenceoftransfusiontransmittedinfectionsinhealthyblooddonorsa5yeartertiarycarehospitalexperience
AT amonkargaythrip seroprevalenceoftransfusiontransmittedinfectionsinhealthyblooddonorsa5yeartertiarycarehospitalexperience
AT desaiheenam seroprevalenceoftransfusiontransmittedinfectionsinhealthyblooddonorsa5yeartertiarycarehospitalexperience
AT valvinitin seroprevalenceoftransfusiontransmittedinfectionsinhealthyblooddonorsa5yeartertiarycarehospitalexperience
AT puranikgururajv seroprevalenceoftransfusiontransmittedinfectionsinhealthyblooddonorsa5yeartertiarycarehospitalexperience